Standard Biotools Inc
(LAB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2000 | 06-2000 | 03-2000 | |
| Cash Flows From Operating Activities | |||
| Net Income | 59,629 | 40,681 | 20,555 |
| Depreciation Amortization | 13,439 | 8,251 | 2,984 |
| Income taxes - deferred | -49 | 72 | 144 |
| Other Working Capital | -141,980 | -123,971 | -81,817 |
| Other Operating Activity | 2,325 | 1,495 | 750 |
| Operating Cash Flow | $-66,636 | $-73,472 | $-57,384 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -2,003 | -1,162 | -498 |
| Net Acquisitions | -184,364 | -184,364 | -184,052 |
| Other Investing Activity | -6,000 | 0 | 0 |
| Investing Cash Flow | $-192,367 | $-185,526 | $-184,550 |
| Cash Flows From Financing Activities | |||
| Debt Issued | 245,693 | 245,693 | 245,693 |
| Financing Cash Flow | $245,693 | $245,693 | $245,693 |
| Beginning Cash Position | 83,774 | 83,774 | 83,774 |
| End Cash Position | 70,464 | 70,469 | 87,533 |
| Net Cash Flow | $-13,310 | $-13,305 | $3,759 |
| Free Cash Flow | |||
| Operating Cash Flow | -66,636 | -73,472 | -57,384 |
| Capital Expenditure | -2,003 | -1,162 | -498 |
| Free Cash Flow | -68,639 | -74,634 | -57,882 |